Statistics for Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC.
Total visits
| views | |
|---|---|
| Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC. | 70 |
Total visits per month
| views | |
|---|---|
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
File Visits
| views | |
|---|---|
| 10.1177_2055217319887191.pdf | 74 |
Top country views
| views | |
|---|---|
| United States | 31 |
| China | 11 |
| Portugal | 8 |
| Canada | 7 |
| France | 3 |
| Israel | 2 |
| Iran | 2 |
| Japan | 2 |
| Germany | 1 |
| Latvia | 1 |
| Seychelles | 1 |